3B BlackBio Dx has informed that 3B BlackBio Dx (the ‘Company’) interacted one to one with Dalmus Capital Management, Mumbai on Saturday, December 20, 2025 at 13:00 hrs India time. The meeting concluded at 14:00 hrs India time. Further noted that information which is already available in public domain was discussed and no unpublished price sensitive information pertaining to the company was shared with the investor. During this investor meeting, the company reiterated the information shared by it through Investor Presentation of Q2-FY26, which was earlier intimated to the Stock Exchanges vide Ref. No.P66/2025-26/57 dated November 13, 2025. Enclosed the web link of the presentation placed before investors after the declaration of the financial results for the quarter and half year ended 30-09-2025 and the investor. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.bseindia.com/xmldata/corpfiling/AttachHis/351b9755-ddaf-4a3c-967e-07f8f28e5338.pdf.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Lenskart Solutions | 515.35 |
| Poly Medicure | 1511.05 |
| Laxmi Denta | 199.00 |
| Nureca Ltd. | 265.35 |
| Hemant Surgical Inds | 301.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: